<DOC>
	<DOCNO>NCT01244880</DOCNO>
	<brief_summary>To evaluate whether PF-02545920 reduces effect ketamine brain activation causal learn measure fMRI compare placebo healthy human subject , evaluate whether behavioral measure abnormal causal learn ketamine reduce treatment PF 02545920 .</brief_summary>
	<brief_title>Effects Of PF-02545920 On Ketamine-Induced Abnormal Prefrontal Brain Response To Associative Learning In Healthy Subjects</brief_title>
	<detailed_description>The study terminate November 2 , 2012 due reassessment likelihood study meeting scientific objective light data investigational drug obtain another clinical study . The decision terminate trial base safety concern .</detailed_description>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Healthy male and/or female subject age 21 45 year , inclusive . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test ) . Right hand determined handedness questionnaire . Able read write English primary language . Female subject pregnant breastfeeding . Any evidence significant psychosislike symptom . Known sensitivity ketamine .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>PF-02545920</keyword>
	<keyword>ketamine</keyword>
	<keyword>fMRI</keyword>
	<keyword>associative Learning</keyword>
</DOC>